As of 2025-07-05, the Relative Valuation of Exagen Inc (XGN) is (10.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.05 USD, the upside of Exagen Inc based on Relative Valuation is -246.0%.
The range of the Relative Valuation is (10.26) - (11.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 16.5x | 16.0x |
| Forward P/E multiples | 10.1x - 15.8x | 13.0x |
| Fair Price | (10.26) - (11.27) | (10.30) |
| Upside | -245.5% - -259.8% | -246.0% |
| Date | P/E |
| 2025-07-03 | -9.91 |
| 2025-07-02 | -9.80 |
| 2025-07-01 | -9.83 |
| 2025-06-30 | -9.81 |
| 2025-06-27 | -9.84 |
| 2025-06-26 | -9.83 |
| 2025-06-25 | -9.52 |
| 2025-06-24 | -9.93 |
| 2025-06-23 | -9.80 |
| 2025-06-20 | -10.16 |
| 2025-06-18 | -10.35 |
| 2025-06-17 | -10.87 |
| 2025-06-16 | -10.46 |
| 2025-06-13 | -10.01 |
| 2025-06-12 | -9.81 |
| 2025-06-11 | -10.21 |
| 2025-06-10 | -10.35 |
| 2025-06-09 | -10.08 |
| 2025-06-06 | -10.19 |
| 2025-06-05 | -10.11 |
| 2025-06-04 | -10.36 |
| 2025-06-03 | -10.39 |
| 2025-06-02 | -10.04 |
| 2025-05-30 | -9.77 |
| 2025-05-29 | -9.81 |
| 2025-05-28 | -9.42 |
| 2025-05-27 | -9.57 |
| 2025-05-23 | -9.28 |
| 2025-05-22 | -8.48 |
| 2025-05-21 | -8.11 |
| 2025-05-20 | -8.38 |
| 2025-05-19 | -8.90 |
| 2025-05-16 | -8.45 |
| 2025-05-15 | -8.07 |
| 2025-05-14 | -8.18 |
| 2025-05-13 | -7.91 |
| 2025-05-12 | -8.11 |
| 2025-05-09 | -8.03 |
| 2025-05-08 | -8.66 |
| 2025-05-07 | -9.60 |
| 2025-05-06 | -9.03 |
| 2025-05-05 | -8.79 |
| 2025-05-02 | -8.46 |
| 2025-05-01 | -8.63 |
| 2025-04-30 | -8.76 |
| 2025-04-29 | -9.67 |
| 2025-04-28 | -9.35 |
| 2025-04-25 | -8.73 |
| 2025-04-24 | -8.22 |
| 2025-04-23 | -8.04 |